2022年健康元药业集团股份有限公司中报

Stock abbreviation: 健康元 Stock code:600380 FORTHEHEALTH FORTHEFUTURE 为明天 为健康 Joincare Pharmaceutical Group Industry Co., Ltd. lnterim Report 2022 【Mission】For the health, For the future 【Vision】Attentively Develop High-quality Medicines and lnnovative Medicines 【Core Values】Putting People at the first place, Valuing Workmanship and Quality, Pursuing Innovation and lntegrity, Promoting Cooperation and Sharing ImportantNotice I The Board of Directors (the “Board”), the Board of Supervisors and directors, supervisors and senior management of the Company hereby warrant the truthfulness, accuracy and completeness of the contents of the interim report (the “Report”), and that there are no false representations, misleading statements or material omissions contained in the Report, and severally and jointly accept responsibility. II All the directors of the Company attended the Board meeting. III The interim report of the Company is unaudited. IV Mr. Zhu Baoguo (朱保国), the person-in-charge of the Company, and Mr. Qiu Qingfeng (邱庆丰), the person-in-charge of the Company’s accounting work and the person-in-charge of the accounting department (the head of the accounting department), declare that they hereby warrant the truthfulness, accuracy and completeness of the financial statements contained in the Report. V Profit distribution plan or plan for conversion of capital reserve to share capital approved by the Board during the Reporting Period Not applicable VI Risk declaration for the forward-looking statements √ Applicable □ N/A The Report contains forward-looking statements which involve the future plans, development strategies, etc. of the Company, yet do not constitute substantive undertakings of the Company to investors. Investors should exercise caution prior to making investment decisions. VII Whether there is non-operating use of funds by the controlling shareholder and their related parties No VIII Whether there is a violation of the prescribed decision-making procedures to provide external guarantees No IX Whether more than half of directors cannot warrant the truthfulness, accuracy and completeness of the Report disclosed by the Company No X Significant risk warnings There is no exceptionally significant risk that will have a material impact on the productions and operations of the Company during the Reporting Period. The Company has described various risks related to productions and operations that the Company may face and the corresponding response measures taken. Please refer to “Risks” in Chapter 3 “Management Discussion and Analysis”. XI Others □ Applicable　√ N/A XII The Report is prepared in both Chinese and English. In case of any discrepancies between two versions, the Chinese version shall prevail. FOR THE HEALTH FOR THE FUTURE lnterimReport2022 1 Table of Contents Financial Highlights 2 Chapter 1 Definitions 4 Chapter 2 Company Profile and Major Financial Indicators 7 Chapter 3 Management Discussion and Analysis 12 Chapter 4 Corporate Governance 35 Chapter 5 EnvironmentalandCorporateSocialResponsibility 40 Chapter 6 Major Events 67 Chapter 7 Changes in Equity and Shareholders 82 Chapter 8 Information on Preferred Shares 87 Chapter 9 Information on Bonds 89 Chapter 10 Financial Statements 91 List of documents available The Financial Statements signed and sealed by the person-in-charge of for inspection the Company, the person-in-charge of the Company’s accounting work and the person-in-charge of the accounting department (the head of the accounting department) The original copies of all documents and announcements of the Company which have been disclosed to the public on the website designated by CSRC during the Reporting Period FinancialHighlights 1. Major financial indicators (RMB100 million) 78.35 85.65 8.01 8.04 6.87 公司代码：600380 公司简称：健康元 健康元药业集团股份有限公司 600380 2022 年半年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、本半年度报告未经审计。 四、公司负责人朱保国、主管会计工作负责人邱庆丰及会计机构负责人（会计主管人员）邱庆丰 声明：保证半年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 不适用 六、前瞻性陈述的风险声明 √适用 □不适用 本报告所涉及的公司未来计划、发展战略等前瞻性陈述,不构成公司对投资者的实质性承诺，请投资者注意投资风险。 七、是否存在被控股股东及其关联方非经营性占用资金情况 ……